ClinicalTrials.gg
RecruitingNCT07853014Updated Oct 1, 2026

Virtual Reality to Reduce Anxiety in Adults Having Lower Wisdom Tooth Surgery

An interventional study of Immersive Virtual Reality (Meta Quest 3) in Dental Anxiety and Mandibular Third Molar, sponsored by Hanoi Medical University. Recruiting at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Hanoi Medical University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2026, registered Sep 2026).
  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 1, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial will evaluate whether immersive virtual reality can reduce anxiety in adults undergoing surgical removal of mandibular third molars under local anesthesia. A total of 120 participants will be assigned to either an immersive virtual reality group or a standard-care control group. Participants in the virtual reality group will use a Meta Quest 3 headset displaying relaxing natural scenery beginning 2-3 minutes before local anesthesia and continuing through completion of surgery. Both groups will undergo the same standardized surgical protocol. The primary outcome is state anxiety during surgery, assessed using the State-Trait Anxiety Inventory-State scale (STAI-S). Secondary outcomes include intraoperative pain and immediate postoperative satisfaction. Additional measures will assess postoperative pain, swelling, mouth opening, wound healing, analgesic use, adverse events and acceptability of virtual reality.

Read the detailed description

This is a single-center, parallel-group randomized controlled trial involving 120 adults scheduled for surgical removal of a mandibular third molar. Eligible participants will be stratified according to baseline trait anxiety (STAI-T \<40 or ≥40). Within each stratum, treatment allocation will use a minimization procedure with a biased-coin probability of 0.80/0.20 to improve balance between groups with respect to dental anxiety measured by the Modified Dental Anxiety Scale, age, and sex. Allocation will be concealed using sequentially numbered, opaque, sealed envelopes.

Participants assigned to the experimental group will use an immersive virtual reality headset (Meta Quest 3) presenting relaxing natural scenery. The headset will be started approximately 2-3 minutes before administration of local anesthesia and will remain in use until completion of the final suture. Participants assigned to the control group will receive standard care without virtual reality.

All mandibular third molar surgeries will follow the same standardized surgical protocol. Participating surgeons will have at least 5 years of surgical experience and will receive protocol-specific training.

State anxiety will be assessed before surgery and immediately after surgery, within 5 minutes after the final suture, with the post-surgical assessment referring to the participant's anxiety experienced during the procedure. Participants will also be followed for postoperative pain, facial swelling, maximum mouth opening, wound healing, sensory disturbances, analgesic consumption, and postoperative complications.

02

Conditions studied

  • Dental Anxiety
  • Mandibular Third Molar

Keywords

  • Virtual Reality
  • Mandibular Third Molar
  • Third Molar Surgery
  • Oral Surgery
  • State-Trait Anxiety Inventory
  • Immersive Virtual Reality
03

In context

Lead sponsor

Hanoi Medical University is the lead sponsor of 57 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults aged 18 years or older. Indication for surgical removal of a mandibular third molar. Mandibular third molar with a Pederson difficulty score of 5 or higher on panoramic radiography.

General health status permitting oral surgery, with no current acute infection, swelling or acute pain at the surgical site.

Able and willing to provide written and comply with the study procedures and scheduled follow-up visits.

Exclusion criteria

Exclusion Criteria:

Severe psychiatric disorder, severe dizziness or a history of significant motion sickness that may interfere with use of virtual reality.

Systemic medical conditions that do not permit surgical treatment, including uncontrolled cardiovascular disease, uncontrolled diabetes mellitus or current use of medication.

Pregnancy or breastfeeding. Current or previous radiotherapy involving the maxillofacial region.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Immersive Virtual Reality

    Participants will receive immersive virtual reality using a Meta Quest 3 headset in addition to standardized surgical care during removal of a mandibular third molar

    Device: Immersive Virtual Reality (Meta Quest 3)

  • No intervention
    Standard Care

    Participants will undergo the same standardized mandibular third molar surgical procedure without virtual reality beyond routine care

Interventions

  • DeviceImmersive Virtual Reality (Meta Quest 3)

    Participants will wear a Meta Quest 3 virtual reality headset with integrated audio displaying relaxing natural scenery. The virtual reality intervention will begin approximately 2-3 minutes before administration of local anesthesia and will continue throughout the surgical procedure until completion of the final suture. The intervention may be discontinued if the participant experiences significant cybersickness, such as dizziness, nausea or discomfort

06

What researchers measure

Primary outcomes

  1. State Anxiety During Surgery Measured by the State-Trait Anxiety Inventory-State (STAI-S)

    State anxiety associated with the surgical procedure will be assessed using the 20-item State-Trait Anxiety Inventory-State (STAI-S). The total score ranges from 20 to 80, with higher scores indicating greater state anxiety. Participants will self-complete the STAI-S within 5 minutes after the final suture as the standardized assessment of anxiety associated with the just-completed surgical procedure.

    Time frame: Within 5 minutes after the final suture on the day of surgery

Secondary outcomes

  1. Pain During Surgery Measured by a 0-10 Numeric Rating Scale

    Pain associated with the just-completed surgical procedure will be self-reported on a 0-10 numeric rating scale, where 0 indicates no pain and 10 indicates the worst pain imaginable. The assessment will be completed within 5 minutes after the final suture.

    Time frame: Within 5 minutes after the final suture on the day of surgery

  2. Immediate Postoperative Satisfaction

    Participant-reported satisfaction with the surgical experience will be assessed using a 0-10 numeric rating scale, with higher scores indicating greater satisfaction.

    Time frame: Within 5 minutes after completion of surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2026
First posted
Oct 1, 2026
StartActual
Jun 9, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jul 30, 2027
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07853014
Lead sponsor
Hanoi Medical University
Responsible party
DUC NGUYEN MINH (Lecturer, Hanoi Medical University) — Principal investigator
First posted
Oct 1, 2026
Start date
Jun 9, 2026
Primary completion
Jun 30, 2027 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Oct 1, 2026

Study contacts

Van Thang Nguyen, DDS, MSc
Contact
drthangvan@gmail.com
+84 849999942
Van Thang Nguyen, DDS, MSc
principal investigator · The University of Danang - School of Medicine and Pharmacy
Duc Nguyen Minh, DDS, PhD
study chair · Hanoi Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion